London Bridge is a modern, hybrid-indica strain defined by its mysterious beginnings. Its precise origins are undocumented, and as breeders have not publicly confirmed a comprehensive lineage, its development remains a subject of speculation within the industry. While some sources acknowledge its connection to London Poundcake, information regarding its broader genetic heritage is currently incomplete, leaving the history of this cultivar largely undefined.

This strain features a complex chemical architecture that is confirmed to range from limonene as the dominant terpene, followed by myrcene, caryophyllene, linalool, beta-pinene, humulene, pinene, and finally terpinolene. Because its specific cannabinoid content represents an estimated average based on published figures rather than batch-specific testing, users can expect an estimated THC potency of approximately 17.7% and a negligible CBD concentration of roughly 0.02%. This terpene-rich composition informs its sensory profile, which is characterized by the distinct aromatic nuances of its dominant limonene and myrcene content.

Cultivators working with London Bridge will find it to be a moderate-difficulty plant that performs well in both indoor and outdoor environments. It reaches maturity with a short 56-day flowering cycle and is capable of producing a high yield. In terms of psychoactive effects, the strain is sought for its ability to induce a state of relaxation and mental focus. These properties make it a frequent choice for users aiming to manage pain, mitigate stress, or assist with sleep. There are currently no recorded offspring or significant genetic progeny associated with this strain.